These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26553253)

  • 1. Stereoselective Modulation of P-Glycoprotein by Chiral Small Molecules.
    Carocci A; Catalano A; Turi F; Lovece A; Cavalluzzi MM; Bruno C; Colabufo NA; Contino M; Perrone MG; Franchini C; Lentini G
    ChemMedChem; 2016 Jan; 11(1):93-101. PubMed ID: 26553253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression.
    Guglielmo S; Contino M; Lazzarato L; Perrone MG; Blangetti M; Fruttero R; Colabufo NA
    ChemMedChem; 2016 Feb; 11(4):374-6. PubMed ID: 26797828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From mixed sigma-2 receptor/P-glycoprotein targeting agents to selective P-glycoprotein modulators: small structural changes address the mechanism of interaction at the efflux pump.
    Abate C; Pati ML; Contino M; Colabufo NA; Perrone R; Niso M; Berardi F
    Eur J Med Chem; 2015 Jan; 89():606-15. PubMed ID: 25462269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning of β-glucosidase and α-galactosidase inhibition by generation and in situ screening of a library of pyrrolidine-triazole hybrid molecules.
    Martínez-Bailén M; Carmona AT; Moreno-Clavijo E; Robina I; Ide D; Kato A; Moreno-Vargas AJ
    Eur J Med Chem; 2017 Sep; 138():532-542. PubMed ID: 28692917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
    Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
    Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new 2,6-prolylxylidide analogues of tocainide as stereoselective blockers of voltage-gated Na(+) channels with increased potency and improved use-dependent activity.
    Franchini C; Corbo F; Lentini G; Bruno G; Scilimati A; Tortorella V; Conte Camerino D; De Luca A
    J Med Chem; 2000 Oct; 43(20):3792-8. PubMed ID: 11020295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid preparation of (3R,4S,5R) polyhydroxylated pyrrolidine-based libraries to discover a pharmacological chaperone for treatment of Fabry disease.
    Cheng WC; Wang JH; Yun WY; Li HY; Hu JM
    Eur J Med Chem; 2017 Jan; 126():1-6. PubMed ID: 27744182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study.
    Shahraki O; Edraki N; Khoshneviszadeh M; Zargari F; Ranjbar S; Saso L; Firuzi O; Miri R
    Drug Des Devel Ther; 2017; 11():407-418. PubMed ID: 28243063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (11)C- and (18)F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission Tomography.
    Cantore M; Benadiba M; Elsinga PH; Kwizera C; Dierckx RA; Colabufo NA; Luurtsema G
    ChemMedChem; 2016 Jan; 11(1):108-18. PubMed ID: 26563728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of highly functionalized barbituric acids and study of their interactions with p-glycoprotein and Mg2+--potential candidates for multi drug resistance modulation.
    Singh P; Kaur J; Bhardwaj A
    Eur J Med Chem; 2010 Mar; 45(3):1256-62. PubMed ID: 20053485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action.
    Sterz K; Möllmann L; Jacobs A; Baumert D; Wiese M
    ChemMedChem; 2009 Nov; 4(11):1897-911. PubMed ID: 19777523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries.
    Pinilla C; Edwards BS; Appel JR; Yates-Gibbins T; Giulianotti MA; Medina-Franco JL; Young SM; Santos RG; Sklar LA; Houghten RA
    Mol Pharmacol; 2013 Sep; 84(3):314-24. PubMed ID: 23788657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.
    Fish PV; Barta NS; Gray DL; Ryckmans T; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4355-9. PubMed ID: 18621528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    Bioorg Med Chem; 2008 May; 16(10):5490-500. PubMed ID: 18455407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and fucosidase inhibitory study of unnatural pyrrolidine alkaloid 4-epi-(+)-codonopsinine.
    Kotland A; Accadbled F; Robeyns K; Behr JB
    J Org Chem; 2011 May; 76(10):4094-8. PubMed ID: 21495694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance.
    Boumendjel A; Di Pietro A; Dumontet C; Barron D
    Med Res Rev; 2002 Sep; 22(5):512-29. PubMed ID: 12210557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective Regulation of P-gp Activity by Clausenamide Enantiomers in Caco-2, KB/KBv and Brain Microvessel Endothelial Cells.
    Zhu CJ; Hua F; Zhu XL; Li M; Wang HX; Yu XM; Li Y
    PLoS One; 2015; 10(8):e0135866. PubMed ID: 26295572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
    Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
    Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.
    Kim N; Meyers KM; Mendez-Andino JL; Warshakoon NC; Ji W; Wos JA; Colson A; Mitchell MC; Davis JR; Pinney BB; Reizes O; Hu XE
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5445-50. PubMed ID: 16879961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.